.On the heels of an FDA being rejected for its own primary rival Novo Nordisk, Eli Lilly is actually...
.Merely a couple of months after application the initial individual in a stage 2 trial for freshly d...
.Eli Lilly's search for weight problems targets has actually led it to the darker genome. The Big Ph...
.Arsenal Biosciences is going on up. The cell treatment business has added on $325 million in ammuni...
.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...
.Aelis Farma's hopes of protecting an easy, beneficial decision on a $100 thousand option repayment ...
.ProKidney has quit one of a pair of period 3 trials for its tissue treatment for renal condition af...
.Vaxcyte unveiled what analysts referred to as "remarkable" stage 1/2 records for its 31-valent pneu...
.Recursion has stumbled via a very early test of its own tech-enabled method to drug revelation, sta...
.Call it a situation of good chemical make up: Acepodia, a biotech based on Nobel Champion scientifi...